KhannaDMcMahonMFurstDE. Anti-tumor necrosis factor α therapy and heart failure: What have we learned and where do we go from here?Arthritis Rheum2004; 50: 1040–50.
2.
NaranjoCABustoUSellersEMSandorPRuizIRobertsEA. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981; 30: 239–45.
3.
Gonzalez-JuanateyCTestaAGarcia-CasteloAGarcia-PorruaCLlorcaJOllierWE. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum2004; 33: 231–8.
4.
WenFQWatanabeKTanakaHYoshidaM. Cytokines and lipopolysaccharide enhance basal and thrombin-stimulated production of PGI2 by cultured human pulmonary artery smooth muscle cells. Prostaglandins Leukot Essent Fatty Acids1997; 56: 185–92.
5.
ShibataMParfenovaHZuckermanSLLefflerCW. Tumor necrosis factor-α induces pial arteriolar dilation in newborn pigs. Brain Res Bull1996; 39: 241–7.
